Enzon Pharmaceuticals, Inc. (ENZN)

Market Cap	962.88M
Revenue (ttm)	356.71M
Net Income	-58.60M
EPS	-0.44
Shares Out	160.48M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,577
Average Volume	1,864
Open	6.34
Previous Close	6.34
Day's Range	6.00 - 6.34
52-Week Range	1.50 - 12.99
Beta	-0.02
RSI	49.05
Earnings Date	May 22, 2026

About Enzon Pharmaceuticals

As of March 26, 2026, Enzon Pharmaceuticals, Inc. was acquired by Viskase Companies, Inc. Enzon Pharmaceuticals, Inc. focuses on non-edible cellulosic, fibrous, and plastic casings used to prepare and package processed meat and poultry products. Enzon Pharmaceuticals, Inc. was incorporated in 1981 and is headquartered in Lombard, Illinois.

• Industry: Packaging & Containers
• Sector: Consumer Discretionary
• Founded: 1981
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: ENZN